Infliximab in extrapulmonary sarcoidosis: Tantalising but inconclusive

European Respiratory Journal

Volumn 31, Issue 6, 2008, Pages 1148-1149

  Wells, A U ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; INFLIXIMAB; PLACEBO; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY;

DRUG EFFICACY; EDITORIAL; HUMAN; LUNG FUNCTION; MEDICAL DECISION MAKING; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; SARCOIDOSIS; CLINICAL TRIAL; EPIDEMIOLOGY; EVIDENCE BASED MEDICINE; NOTE;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; HUMANS; SARCOIDOSIS; SELECTION BIAS;

EID: 49649120921     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00049808     Document Type: Editorial

References (8)

1. Judson MA, Baughman RP, Costabel U, et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J 2008; 31: 1189-1196.
2. Wells AU, Latsi P, McCune WJ. Daily cyclophosphamide for scleroderma: are patients with the most to gain unrepresented in this trial? Am J Respir Crit Care Med 2007; 176: 952-953.
3. Baughman RP, Drent M, Kavuru M, et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006; 174: 795-802.
4. Tashkin DP, Elashoff R, Clements PJ, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006; 354: 2655-2666.
5. Hoyles RK, Ellis RW, Wellsbury J, et al. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum 2006; 54: 3962-3970.
6. Tashkin DP, Elashoff R, Clements PJ, et al. Effect of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med 2007; 176: 1026-1034.
7. Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yanger H. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 75-86.
8. Wash YS, Rose CS, Murphy JR, et al. A new tool to assess sarcoidosis severity. Chest 2006; 129: 1234-1245.